Michael holds a B.A. in city planning, history and molecular biophysics and biochemistry from Yale College; attended the Woodrow Wilson School at Princeton University; and has an M.B.A. from Harvard Business School.
Michael recently completed his term as the founding CEO of Kolltan Pharmaceuticals, a Yale biotechnology spin off developing monoclonal antibody cancer therapeutics. He is also the chairman of the board of PTC Therapeutics, Inc. and the independent director of LCPI, the major subsidiary of the post bankruptcy Lehman Brothers estate. Previously he served as chair of the Investment Committee of Credit Suisse First Boston Equity Partners and as a director of a number of its portfolio companies. He is a Governor and Treasurer of the New York Academy of Science, a Trustee of Phillips Academy Andover, and since 1997, a professor at Yale School of Management. He was previously a managing director of Morgan Stanley & Co. Inc, president of Morgan Stanley Leveraged Capital Funds, a managing director of Shearson Lehman Brothers Kuhn Loeb, and a managing director and chief financial officer of Lehman Brothers Kuhn Loeb.
A licensed pilot, Michael is also a photographer, musician, and an enthusiastic skier and tennis player. He lives with his wife, Kuni, and their two sons in Connecticut.more » « less